002714:SZSEMuyuan Foods Co., Ltd. Class A Analysis
Data as of 2026-08-29 - not real-time
CN¥41.68
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Muyuan Foods Group Co., Ltd. trades at ¥41.68, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has gained 4.6% over the past 30 days. With RSI at 63.4 the momentum picture is approaching overbought, alongside a bullish MACD signal. Price has been bracketed by support at ¥37.63 and resistance at ¥41.85.
On valuation the read is undervalued — an earnings multiple of 12.7, absent a reliable peer benchmark. The average analyst target implies 25.7% above today's level. Revenue is contracting at 26.9% on a -0.9% profit margin. The 4.63% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 29.8%, a beta of 0.10 and a maximum drawdown of 44.9%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
On valuation the read is undervalued — an earnings multiple of 12.7, absent a reliable peer benchmark. The average analyst target implies 25.7% above today's level. Revenue is contracting at 26.9% on a -0.9% profit margin. The 4.63% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 29.8%, a beta of 0.10 and a maximum drawdown of 44.9%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Top Market Events
HONG KONG, Feb 2, 2026 - ACN Newswire - On 29 January, Muyuan Foods Co.HONG KONG, Feb 6, 2026 - ACN Newswire - On 6 February, Muyuan Foods Co.Investing11monMuyuan Foodstuff Co LtdWe've identified the following companies as similar to Muyuan Foodstuff Co Ltd...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 43.64
- MACD momentum is positive
- Maximum drawdown of 44.9%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 43.64
- Analyst targets imply +25.7% versus the current price
- MACD momentum is positive
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -0.9%
- Analyst targets imply +25.7% versus the current price
- Negative return on equity of -1.3%
Key Metrics & Analysis
Financial Health
Revenue Growth-26.90%
Profit Margin-0.88%
P/E Ratio12.7
ROE-1.31%
ROA0.71%
Debt/Equity96.41
P/B Ratio3.0
Op. Cash FlowCN¥10.5B
Free Cash FlowCN¥2.5B
Technical Analysis
TrendNeutral
RSI63.4
SupportCN¥37.63
ResistanceCN¥41.85
MA 20CN¥39.50
MA 50CN¥38.37
MA 200CN¥43.64
MACDBullish
VolumeStable
Fear & Greed Index95.66
Valuation
Target PriceCN¥52.41
Upside/Downside25.74%
GradeUndervalued
TypeValue
Dividend Yield4.63%
Risk Assessment
Beta0.10
Volatility29.83%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.